8 results
·
17ms
·
Sources: EU EUDAMED, US FDA
VISION CARDIOPLEGIA DELIVERY SYSTEM
FDA 510(k)
FDA Class 2
·Cardiovascular
EMIT(R) II CANNABINOID 50 NG ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
NEUROTRAC II
FDA 510(k)
FDA Class 2
·Neurology
C-TAPER TRIAL HEAD 36MM -5
FDA Adverse Event
Malfunction
·STRYKER ORTHOPAEDICS-MAHWAH·Product code LXH·February 15, 2013
PRECISION TEST STRIPS
FDA Adverse Event
Malfunction
·ABBOTT DIABETES CARE, INC. USA·Product code NBW·January 20, 2011
UNKNOWN DEPUY HIP LINER
FDA Adverse Event
Injury
·DEPUY ORTHOPAEDICS, INC.·Product code KWA·July 29, 2014
I-STAT PTPLUS CARTRIDGE
FDA Adverse Event
Malfunction
·ABBOTT POINT OF CARE·Product code GJS·October 29, 2024
Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017